Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Mouse ANGPT2/Ang2 Protein, N-His

Recombinant Mouse ANGPT2/Ang2 Protein, N-His from ProteoGenix; catalogue ARO-P11113; research use only.

SKU:
ABM141551-1
Manufacturer SKU
ARO-P11113
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Structure of Recombinant Mouse ANGPT2/Ang2 Protein

Recombinant Mouse ANGPT2/Ang2 Protein is a type of recombinant protein that is derived from the Angiopoietin-2 (Ang2) gene found in mice. It is a 60 kDa glycoprotein that is composed of 496 amino acids. The protein has a signal peptide at the N-terminus, a coiled-coil domain, and a C-terminal fibrinogen-like domain. The recombinant protein is produced by inserting the Ang2 gene into a suitable expression vector and then expressing it in a host organism such as E. coli or mammalian cells.

Activity of Recombinant Mouse ANGPT2/Ang2 Protein

Recombinant Mouse ANGPT2/Ang2 Protein plays a crucial role in regulating angiogenesis, the process by which new blood vessels are formed from pre-existing ones. It acts as a ligand for the Tie2 receptor, which is expressed on the surface of endothelial cells, smooth muscle cells, and hematopoietic stem cells. The binding of Ang2 to Tie2 leads to the activation of downstream signaling pathways that promote angiogenesis.

In addition to its pro-angiogenic activity, Recombinant Mouse ANGPT2/Ang2 Protein also has anti-apoptotic and anti-inflammatory effects on endothelial cells. It can protect endothelial cells from apoptosis induced by various stimuli, such as oxidative stress and TNF-α. Moreover, it can inhibit the production of pro-inflammatory cytokines and adhesion molecules, thereby reducing inflammation in the vasculature.

Application of Recombinant Mouse ANGPT2/Ang2 Protein

Recombinant Mouse ANGPT2/Ang2 Protein has a wide range of applications in both research and clinical settings. Its pro-angiogenic activity makes it a valuable tool for studying the mechanisms of angiogenesis and for developing new therapies for diseases that involve abnormal blood vessel formation, such as cancer and cardiovascular diseases.

One of the most important applications of Recombinant Mouse ANGPT2/Ang2 Protein is in the field of cancer research. It has been shown to promote tumor growth and metastasis by stimulating the formation of new blood vessels. Therefore, targeting Ang2 with specific inhibitors or antibodies has emerged as a potential strategy for inhibiting tumor growth and metastasis.

In addition to cancer, Recombinant Mouse ANGPT2/Ang2 Protein has also been implicated in various other diseases. For instance, it has been shown to play a role in the development of diabetic retinopathy, a common complication of diabetes that involves abnormal blood vessel growth in the retina. In this context, targeting Ang2 with specific inhibitors may have therapeutic potential for treating diabetic retinopathy.

Furthermore, Recombinant Mouse ANGPT2/Ang2 Protein has been studied as a potential therapeutic for cardiovascular diseases, such as atherosclerosis and ischemic heart disease. Its ability to promote angiogenesis and inhibit inflammation makes it a promising candidate for promoting the repair of damaged blood vessels and improving blood flow in these conditions.

In conclusion, Recombinant Mouse ANGPT2/Ang2 Protein is a versatile and important tool in the field of angiogenesis research. Its structure, activity, and various applications make it a valuable protein for understanding the mechanisms of angiogenesis and developing new treatments for diseases involving abnormal blood vessel formation. Continued research on this protein will help to further elucidate its role in various diseases and may lead to the development of novel therapies.

ProteoGenix catalogue number ARO-P11113. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 26.47 kDa; Fragment: Asp283-Phe496; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
Agpt2, Angpt2, Angiopoietin-2, ANG-2
Host species
E. coli
Source organism
Mouse
Molecular weight
26.47 kDa
Sequence fragment
Asp283-Phe496
Sequence
DCAEIFKSGLTTSGIYTLTFPNSTEEIKAYCDMDVGGGGWTVIQHREDGSVDFQRTWKEYKEGFGSPLGEYWLGNEFVSQLTGQHRYVLKIQLKDWEGNEAHSLYDHFYLAGEESNYRIHLTGLTGTAGKISSISQPGSDFSTKDSDNDKCICKCSQMLSGGWWFDACGPSNLNGQYYPQKQNTNKFNGIKWYYWKGSGYSLKATTMMIRPADF
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P11113
UniProt accession
O35608
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£239.00£191.20